作者
Shanu Modi,William Jacot,Toshinari Yamashita,Joohyuk Sohn,María Vidal,Eriko Tokunaga,Junji Tsurutani,Naoto T. Ueno,Aleix Prat,Yee Soo Chae,Keun Seok Lee,Naoki Niikura,Yeon Hee Park,Binghe Xu,Xiaojia Wang,Miguel Gil‐Gil,Wěi Li,Jean‐Yves Pierga,Seock‐Ah Im,Halle C. F. Moore,Hope S. Rugo,Rinat Yerushalmi,Flora Zagouri,Andrea Gombos,Sung‐Bae Kim,Qiang Liu,Ting Luo,Cristina Saura,Peter Schmid,Tao Sun,Dhiraj Gambhire,Lotus Yung,Yibin Wang,Jasmeet Singh,Patrik Vitazka,Gerold Meinhardt,Nadia Harbeck,David Cameron
摘要
Among breast cancers without human epidermal growth factor receptor 2 (HER2) amplification, overexpression, or both, a large proportion express low levels of HER2 that may be targetable. Currently available HER2-directed therapies have been ineffective in patients with these "HER2-low" cancers.
Grayball
MchemG
迟大猫
爱静静
back you up
开心岩
VDC
归尘
迷人秋烟
iNk
小白
andrele
竹筏过海
笔记本
遇上就这样吧
英勇的鼠标
小杨同学
YSM
zho
Xiaoxiao
皖公网安备34019202002308
